| Cannabidiol in humans—the quest for therapeutic targets S Zhornitsky, S Potvin Pharmaceuticals 5 (5), 529-552, 2012 | 307 | 2012 |
| Oral versus long-acting injectable antipsychotics in the treatment of schizophrenia and special populations at risk for treatment nonadherence: a systematic review S Zhornitsky, E Stip Schizophrenia research and treatment 2012, 2012 | 121 | 2012 |
| Depression in multiple sclerosis: a long-term longitudinal study MW Koch, S Patten, S Berzins, S Zhornitsky, J Greenfield, W Wall, ... Multiple Sclerosis Journal 21 (1), 76-82, 2015 | 111 | 2015 |
| Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes S Zhornitsky, KA McKay, LM Metz, CE Teunissen, M Rangachari Multiple sclerosis and related disorders 5, 53-65, 2016 | 110 | 2016 |
| Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis S Potvin, S Zhornitsky, E Stip Canadian journal of psychiatry. Revue canadienne de psychiatrie 60 (3 Suppl …, 2015 | 87 | 2015 |
| Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients S Zhornitsky, É Rizkallah, T Pampoulova, JP Chiasson, O Lipp, E Stip, ... Psychiatry Research 200 (2-3), 237-241, 2012 | 74 | 2012 |
| Prolactin in multiple sclerosis S Zhornitsky, VW Yong, S Weiss, LM Metz Multiple Sclerosis Journal 19 (1), 15-23, 2013 | 67 | 2013 |
| Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials S Zhornitsky, S Potvin, H Moteshafi, S Dubreucq, PP Rompre, E Stip International clinical psychopharmacology 26 (4), 183-192, 2011 | 58 | 2011 |
| Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis S Zhornitsky, E Rizkallah, T Pampoulova, JP Chiasson, E Stip, ... Journal of clinical psychopharmacology 30 (4), 417-424, 2010 | 56 | 2010 |
| Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair S Zhornitsky, V Wee Yong, MW Koch, A Mackie, S Potvin, SB Patten, ... CNS neuroscience & therapeutics 19 (10), 737-744, 2013 | 55 | 2013 |
| The effects of age on reward magnitude processing in the monetary incentive delay task I Dhingra, S Zhang, S Zhornitsky, TM Le, W Wang, HH Chao, I Levy, ... Neuroimage 207, 116368, 2020 | 53 | 2020 |
| Sex differences in the interacting roles of impulsivity and positive alcohol expectancy in problem drinking: A structural brain imaging study JS Ide, S Zhornitsky, S Hu, S Zhang, JH Krystal, RL Chiang-shan Neuroimage: clinical 14, 750-759, 2017 | 47 | 2017 |
| A randomized controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia E Stip, PD Vincent, J Sablier, C Guevremont, S Zhornitsky, C Tranulis Frontiers in pharmacology 4, 100, 2013 | 46 | 2013 |
| Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study S Zhornitsky, J Greenfield, MW Koch, SB Patten, C Harris, W Wall, ... PLoS One 10 (4), e0123824, 2015 | 42 | 2015 |
| Resting state functional connectivity of the amygdala and problem drinking in non-dependent alcohol drinkers S Hu, JS Ide, HH Chao, S Zhornitsky, KA Fischer, W Wang, S Zhang, ... Drug and alcohol dependence 185, 173-180, 2018 | 39 | 2018 |
| Resting state functional connectivity of the lateral and medial hypothalamus in cocaine dependence: an exploratory study S Zhang, W Wang, S Zhornitsky, CR Li Frontiers in Psychiatry 9, 390158, 2018 | 38 | 2018 |
| The interrelationship of body mass index with gray matter volume and resting-state functional connectivity of the hypothalamus TM Le, DL Liao, J Ide, S Zhang, S Zhornitsky, W Wang, CSR Li International Journal of Obesity 44 (5), 1097-1107, 2020 | 37 | 2020 |
| Sexual affordances, perceptual-motor invariance extraction and intentional nonlinear dynamics: sexually deviant and non-deviant patterns in male subjects. BS Renaud P, Goyette M, Chartier S, Zhornitski S, Trottier D, Rouleau JL ... Nonlinear dynamics, psychology, and life sciences 14 (4), 463-89, 2010 | 37 | 2010 |
| Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis S Zhornitsky, TA Johnson, LM Metz, S Weiss, VW Yong Journal of neuroinflammation 12, 1-7, 2015 | 36 | 2015 |
| Gray matter volumetric correlates of behavioral activation and inhibition system traits in children: An exploratory voxel-based morphometry study of the ABCD project data JS Ide, HT Li, Y Chen, TM Le, CSP Li, S Zhornitsky, CSR Li Neuroimage 220, 117085, 2020 | 35 | 2020 |
